MedTrace Logo

A Randomized, Double-blind Clinical Trial on the Efficacy of a Dietary Formulation Containing Medium-chain Triglycerides (MCT) and Fiber in Patients With Psoriatic Arthritis

NCT06990152 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-04-20

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the effects of a formulation containing medium-chain triglycerides (MCTs) and vegetable fibers on the quality of life of patients with psoriatic arthritis, by monitoring the patients over a period of 3 months in a single-center interventional study. As secondary objectives, the study will assess the effects of the same formulation on disease activity and on certain blood parameters and dietary habits.

Conditions

  • Psoriatic Arthritis (PsA)

Interventions

OTHER

MCTs and fiber

Water-soluble powder containing medium-chain triglycerides, soluble and unsoluble fiber.

OTHER

Placebo powder

Water-soluble powder containing no medium-chain triglycerides and no fiber.

Sponsors & Collaborators

  • ASST Gaetano Pini-CTO

    collaborator OTHER

  • Dr. Schär AG / SPA

    lead INDUSTRY

Principal Investigators

  • Francesca Ingegnoli, Professor · ASST Gaetano Pini CTO, UOC Clinica Reumatologica

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-16
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06990152 on ClinicalTrials.gov